Skip to main content
You are here:
Print

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Table of Contents